Jinhyuk Choi1, Tae Gyu Oh2, Hee-Won Jung1, Kun-Young Park1, Hyemi Shin1, Taehee Jo1, Du-Seock Kang1, Dipanjan Chanda3, Sujung Hong1, Jina Kim4, Hayoung Hwang4, Moongi Ji5, Minkyo Jung6, Takashi Shoji7, Ayami Matsushima8, Pilhan Kim1, Ji Young Mun6, Man-Jeong Paik5, Sung Jin Cho4, In-Kyu Lee9, David C Whitcomb10, Phil Greer11, Brandon Blobner12, Mark O Goodarzi13, Stephen J Pandol14, Jerome I Rotter15, Weiwei Fan2, Sagar P Bapat16, Ye Zheng17, Chris Liddle18, Ruth T Yu2, Annette R Atkins2, Michael Downes2, Eiji Yoshihara19, Ronald M Evans20, Jae Myoung Suh21. 1. Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. 2. Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California. 3. Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea; Bio-Medical Research Institute, Kyungpook National University Hospital, Daegu, Republic of Korea. 4. New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea. 5. College of Pharmacy, Sunchon National University, Suncheon, Republic of Korea. 6. Neural Circuit Research Group, Korea Brain Research Institute, Daegu, Republic of Korea. 7. Department of Medicine, Kyoto University, Kyoto, Japan. 8. Laboratory of Structure-Function Biochemistry, Department of Chemistry, Faculty of Science, Kyushu University, Fukuoka, Japan. 9. Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea; Bio-Medical Research Institute, Kyungpook National University Hospital, Daegu, Republic of Korea; Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea; Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. 10. Ariel Precision Medicine, Pittsburgh, Pennsylvania; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; Department of Cell Biology and Molecular Physiology and the Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania. 11. Ariel Precision Medicine, Pittsburgh, Pennsylvania; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. 12. Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. 13. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California. 14. Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, California; Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, California. 15. The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California; Departments of Pediatrics and Human Genetics, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California. 16. Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California; Department of Laboratory Medicine, University of California-San Francisco, San Francisco, California; Diabetes Center, University of California-San Francisco, San Francisco, California; Nomis Laboratories for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California. 17. Nomis Laboratories for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, California. 18. Storr Liver Centre, Westmead Institute for Medical Research and Sydney School of Medicine, University of Sydney, Westmead, New South Wales, Australia. 19. Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California; The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California; David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California. Electronic address: eiji.yoshihara@lundquist.org. 20. Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, California. Electronic address: evans@salk.edu. 21. Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. Electronic address: jmsuh@kaist.ac.kr.
Abstract
BACKGROUND & AIMS: Mitochondrial dysfunction disrupts the synthesis and secretion of digestive enzymes in pancreatic acinar cells and plays a primary role in the etiology of exocrine pancreas disorders. However, the transcriptional mechanisms that regulate mitochondrial function to support acinar cell physiology are poorly understood. Here, we aim to elucidate the function of estrogen-related receptor γ (ERRγ) in pancreatic acinar cell mitochondrial homeostasis and energy production. METHODS: Two models of ERRγ inhibition, GSK5182-treated wild-type mice and ERRγ conditional knock-out (cKO) mice, were established to investigate ERRγ function in the exocrine pancreas. To identify the functional role of ERRγ in pancreatic acinar cells, we performed histologic and transcriptome analysis with the pancreas isolated from ERRγ cKO mice. To determine the relevance of these findings for human disease, we analyzed transcriptome data from multiple independent human cohorts and conducted genetic association studies for ESRRG variants in 2 distinct human pancreatitis cohorts. RESULTS: Blocking ERRγ function in mice by genetic deletion or inverse agonist treatment results in striking pancreatitis-like phenotypes accompanied by inflammation, fibrosis, and cell death. Mechanistically, loss of ERRγ in primary acini abrogates messenger RNA expression and protein levels of mitochondrial oxidative phosphorylation complex genes, resulting in defective acinar cell energetics. Mitochondrial dysfunction due to ERRγ deletion further triggers autophagy dysfunction, endoplasmic reticulum stress, and production of reactive oxygen species, ultimately leading to cell death. Interestingly, ERRγ-deficient acinar cells that escape cell death acquire ductal cell characteristics, indicating a role for ERRγ in acinar-to-ductal metaplasia. Consistent with our findings in ERRγ cKO mice, ERRγ expression was significantly reduced in patients with chronic pancreatitis compared with normal subjects. Furthermore, candidate locus region genetic association studies revealed multiple single nucleotide variants for ERRγ that are associated with chronic pancreatitis. CONCLUSIONS: Collectively, our findings highlight an essential role for ERRγ in maintaining the transcriptional program that supports acinar cell mitochondrial function and organellar homeostasis and provide a novel molecular link between ERRγ and exocrine pancreas disorders.
BACKGROUND & AIMS: Mitochondrial dysfunction disrupts the synthesis and secretion of digestive enzymes in pancreatic acinar cells and plays a primary role in the etiology of exocrine pancreas disorders. However, the transcriptional mechanisms that regulate mitochondrial function to support acinar cell physiology are poorly understood. Here, we aim to elucidate the function of estrogen-related receptor γ (ERRγ) in pancreatic acinar cell mitochondrial homeostasis and energy production. METHODS: Two models of ERRγ inhibition, GSK5182-treated wild-type mice and ERRγ conditional knock-out (cKO) mice, were established to investigate ERRγ function in the exocrine pancreas. To identify the functional role of ERRγ in pancreatic acinar cells, we performed histologic and transcriptome analysis with the pancreas isolated from ERRγ cKO mice. To determine the relevance of these findings for human disease, we analyzed transcriptome data from multiple independent human cohorts and conducted genetic association studies for ESRRG variants in 2 distinct human pancreatitis cohorts. RESULTS: Blocking ERRγ function in mice by genetic deletion or inverse agonist treatment results in striking pancreatitis-like phenotypes accompanied by inflammation, fibrosis, and cell death. Mechanistically, loss of ERRγ in primary acini abrogates messenger RNA expression and protein levels of mitochondrial oxidative phosphorylation complex genes, resulting in defective acinar cell energetics. Mitochondrial dysfunction due to ERRγ deletion further triggers autophagy dysfunction, endoplasmic reticulum stress, and production of reactive oxygen species, ultimately leading to cell death. Interestingly, ERRγ-deficient acinar cells that escape cell death acquire ductal cell characteristics, indicating a role for ERRγ in acinar-to-ductal metaplasia. Consistent with our findings in ERRγ cKO mice, ERRγ expression was significantly reduced in patients with chronic pancreatitis compared with normal subjects. Furthermore, candidate locus region genetic association studies revealed multiple single nucleotide variants for ERRγ that are associated with chronic pancreatitis. CONCLUSIONS: Collectively, our findings highlight an essential role for ERRγ in maintaining the transcriptional program that supports acinar cell mitochondrial function and organellar homeostasis and provide a novel molecular link between ERRγ and exocrine pancreas disorders.
Authors: F Strappazzon; F Nazio; M Corrado; V Cianfanelli; A Romagnoli; G M Fimia; S Campello; R Nardacci; M Piacentini; M Campanella; F Cecconi Journal: Cell Death Differ Date: 2015-03 Impact factor: 15.828
Authors: C Benedikt Westphalen; Yoshihiro Takemoto; Takayuki Tanaka; Marina Macchini; Zhengyu Jiang; Bernhard W Renz; Xiaowei Chen; Steffen Ormanns; Karan Nagar; Yagnesh Tailor; Randal May; Youngjin Cho; Samuel Asfaha; Daniel L Worthley; Yoku Hayakawa; Aleksandra M Urbanska; Michael Quante; Maximilian Reichert; Joshua Broyde; Prem S Subramaniam; Helen Remotti; Gloria H Su; Anil K Rustgi; Richard A Friedman; Barry Honig; Andrea Califano; Courtney W Houchen; Kenneth P Olive; Timothy C Wang Journal: Cell Stem Cell Date: 2016-04-07 Impact factor: 24.633
Authors: William A Alaynick; Richard P Kondo; Wen Xie; Weimin He; Catherine R Dufour; Michael Downes; Johan W Jonker; Wayne Giles; Robert K Naviaux; Vincent Giguère; Ronald M Evans Journal: Cell Metab Date: 2007-07 Impact factor: 27.287
Authors: Karen M Davies; Claudio Anselmi; Ilka Wittig; José D Faraldo-Gómez; Werner Kühlbrandt Journal: Proc Natl Acad Sci U S A Date: 2012-08-03 Impact factor: 11.205
Authors: Svetlana G Voronina; Stephanie L Barrow; Alec W M Simpson; Oleg V Gerasimenko; Gabriela da Silva Xavier; Guy A Rutter; Ole H Petersen; Alexei V Tepikin Journal: Gastroenterology Date: 2010-01-25 Impact factor: 22.682
Authors: David C Whitcomb; Jessica LaRusch; Alyssa M Krasinskas; Lambertus Klei; Jill P Smith; Randall E Brand; John P Neoptolemos; Markus M Lerch; Matt Tector; Bimaljit S Sandhu; Nalini M Guda; Lidiya Orlichenko; Samer Alkaade; Stephen T Amann; Michelle A Anderson; John Baillie; Peter A Banks; Darwin Conwell; Gregory A Coté; Peter B Cotton; James DiSario; Lindsay A Farrer; Chris E Forsmark; Marianne Johnstone; Timothy B Gardner; Andres Gelrud; William Greenhalf; Jonathan L Haines; Douglas J Hartman; Robert A Hawes; Christopher Lawrence; Michele Lewis; Julia Mayerle; Richard Mayeux; Nadine M Melhem; Mary E Money; Thiruvengadam Muniraj; Georgios I Papachristou; Margaret A Pericak-Vance; Joseph Romagnuolo; Gerard D Schellenberg; Stuart Sherman; Peter Simon; Vijay P Singh; Adam Slivka; Donna Stolz; Robert Sutton; Frank Ulrich Weiss; C Mel Wilcox; Narcis Octavian Zarnescu; Stephen R Wisniewski; Michael R O'Connell; Michelle L Kienholz; Kathryn Roeder; M Michael Barmada; Dhiraj Yadav; Bernie Devlin Journal: Nat Genet Date: 2012-11-11 Impact factor: 38.330
Authors: Gina M DeNicola; Florian A Karreth; Timothy J Humpton; Aarthi Gopinathan; Cong Wei; Kristopher Frese; Dipti Mangal; Kenneth H Yu; Charles J Yeo; Eric S Calhoun; Francesca Scrimieri; Jordan M Winter; Ralph H Hruban; Christine Iacobuzio-Donahue; Scott E Kern; Ian A Blair; David A Tuveson Journal: Nature Date: 2011-07-06 Impact factor: 49.962